Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Paper
  • Published:

Cell death in irradiated prostate epithelial cells: role of apoptotic and clonogenic cell kill

Prostate Cancer and Prostatic Diseases volume 6, pages 73–85 (2003)Cite this article

Abstract

Dose-escalated conformal radiotherapy is increasingly being used to radically treat prostate cancer with encouraging results and minimal long-term toxicity, yet little is known regarding the response of normal or malignant prostate cells to ionizing radiation (IR). To clarify the basis for cell killing during prostate cancer radiotherapy, we determined the IR-induced expression of several apoptotic- (bax, bcl-2, survivin and PARP) and G1-cell cycle checkpoint- (p53 and p21WAF1/Cip1) related proteins, in both normal (PrEC-epithelial and PrSC-stromal) and malignant (LNCaP, DU-145 and PC-3; all epithelial) prostate cells. For these experiments, we chose doses ranging from 2 to 10 Gy, to be representative of the 1.8–2 Gy daily clinical fractions given during curative radiotherapy and the 8–10 Gy single doses given in palliative radiotherapy. We observed that IR-induced bax and p21WAF1/Cip1 protein expression were attenuated selectively in normal stromal and epithelial cell cultures, yet maintained their p53-dependency in malignant cell lines. For each cell culture, we also determined total apoptotic and overall radiation cell kill using a short-term nuclear morphologic assay and a long-term clonogenic survival assay, respectively. Clonogenic survival, as measured by the surviving fraction at 2 Gy (SF2), ranged from 0.05 (PrEC) to 0.55 (DU-145), suggesting that malignant prostate cells are more radioresistant than normal prostate cells, for this series. IR-induced apoptotic cell kill was minimal (less than 6% cell after a dose of 10 Gy at times of 24–96 h) and was not dose-dependent. Furthermore, apoptotic kill was not correlated with either molecular apoptotic response or clonogenic cell kill. Using a flow cytometric proliferation assay with the PrSC (stromal) and DU-145 (epithelial) representative cultures, we observed that a senescent-like phenotype (SLP) emerges within a sub-population of cells post-irradiation that is non-clonogenic. Terminal growth arrest was dose-responsive at 96 h following irradiation and associated with long-term expression of both p21WAF1/Cip1 and p16INK4a genes. Future strategies for prostate radiotherapy prediction or novel treatments should additionally focus on terminal growth arrest as an important endpoint in prostate cancer therapy.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 2
Figure 1
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  1. Lukka H, et al. Controversies in prostate cancer radiotherapy: consensus development. Can J Urol 2001; 8: 1314–1322.

    CAS  PubMed  Google Scholar 

  2. Dearnaley DP . Radiotherapy and combined modality approaches in localised prostate cancer. Eur J Cancer 2001; 37: S137–145.

    Article  Google Scholar 

  3. Bristow RG, Hill P . Molecular and cellular basis of radiotherapy. In: Tannock IF and Hill RP (eds). The Basic Science of Oncology. McGraw-Hill: Toronto. 1998. pp. 295–321.

    Google Scholar 

  4. Wong CS, Hill RP . Experimental Radiotherapy. In: Tannock IF and Hill RP (eds). The Basic Science of Oncology. 3rd edn. McGraw-Hill: Toronto. 1998. pp. 322–349.

    Google Scholar 

  5. Sandford NL, Searle JW, Kerr JF . Successive waves of apoptosis in the rat prostate alter repeated withdrawal of testosterone stimulation. Pathology 1984; 16: 400–410.

    Article  Google Scholar 

  6. Kyprianou N, Issacs JT . Expression of transforming growth factor-beta in rat ventral prostate during castration-induced programmed cell death. Mol Endocrinol 1989; 3: 1515–1522.

    Article  CAS  Google Scholar 

  7. Bruckheimer EM, et al. The impact of bcl-2 expression and bax deficiency on prostate homeostasis in vivo. Oncogene 2000; 19: 2404–2412.

    Article  CAS  Google Scholar 

  8. Westin P, Stattin P, Darnber JE, Bergh A . Castration therapy rapidly induces apoptosis in a minority and decreases cell proliferation in a majority of human prostatic tumors. Am J Pathol 1995; 146: 1368–1375.

    CAS  PubMed  PubMed Central  Google Scholar 

  9. Rakozy C, et al. Expression of bcl-2, p53, and p21 in benign and malignant prostatic tissue before and after radiation therapy. Mod Pathol 1998; 11: 892–899.

    CAS  PubMed  Google Scholar 

  10. Grossfeld GD, et al. Locally recurrent prostate tumors following either radiation therapy or radical prostatectomy have changes in Ki-67 labeling index, p53 and bcl-2 immunoreactivity. J Urol 1998; 159: 1437–1443.

    Article  CAS  Google Scholar 

  11. Bristow RG, Benchimol S, Hill RP . The p53 gene as a modifier of intrinsic radiosensitivity: implications for radiotherapy. Radiother Oncol 1996; 40: 197–223.

    Article  CAS  Google Scholar 

  12. Bristow RG, Benchimol S, Hill R . p53 protein expression or protein function?. Int J Radiat Oncol Biol Phys 1996; 35: 1123–1125.

    Article  CAS  Google Scholar 

  13. Dewey WC, Ling CC, Meyn RE . Radiation-induced apoptosis: relevance to radiotherapy. Int J Radiat Oncol Biol Phys 1995; 33: 781–796.

    Article  CAS  Google Scholar 

  14. Olive PL, Vikse CM, Vanderbyl S . Increase in the fraction of necrotic, not apoptotic, cells in SiHa xenograft tumours shortly after irradiation. Radiother Oncol 1999; 50: 113–119.

    Article  CAS  Google Scholar 

  15. Stephens LC, et al. Development of apoptosis in irradiated murine tumors as a function of time and dose. Radiat Res 1993; 135: 75–80.

    Article  CAS  Google Scholar 

  16. Tannock IF, Lee C . Evidence against apoptosis as a major mechanism for reproductive cell death following treatment of cell lines with anti-cancer drugs. Br J Cancer 2001; 84: 100–105.

    Article  CAS  Google Scholar 

  17. Schwarze SR, et al. Role of cyclin-dependent kinase inhibitors in the growth arrest at senescence in human prostate epithelial and uroepithelial cells. Oncogene 2001; 20: 8184–8192.

    Article  CAS  Google Scholar 

  18. Stein GH, Drullinger LF, Soulard A, Dulic V . Differential roles for cyclin-dependent kinase inhibitors p21 and p16 in the mechanisms of senescence and differentiation in human fibroblasts. Mol Cell Biol 1999; 19: 2109–2117.

    Article  CAS  Google Scholar 

  19. Chang BD, et al. A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents. Cancer Res 1999; 59: 3761–3767.

    CAS  PubMed  Google Scholar 

  20. Lyons AB, Hasbold J, Hodgkin PD . Flow cytometric analysis of cell division history using dilution of carboxyfluorescein diacetate succinimidyl ester, a stably integrated fluorescent probe. Meth Cell Biol 2001; 63: 375–398.

    Article  CAS  Google Scholar 

  21. Soucie EL, et al. Myc protentiates apoptosis by stimulating Bax activity at the mitochondria. Mol Cell Biol 2001; 21: 4725–4736.

    Article  CAS  Google Scholar 

  22. Garzotto M, et al. Reversal of radiation resistance in LNCaP cells by targeting apoptosis through ceramide synthase. Cancer Res 1999; 59: 5194–5201.

    CAS  PubMed  Google Scholar 

  23. Pollack A, et al. Lack of prostate cancer radiosensitization by androgen deprivation. Int J Radiat Oncol Biol Phys 2001; 51: 1002–1007.

    Article  CAS  Google Scholar 

  24. Bristow RG, et al. Radioresistant MTp53-expressing rat embryo cell transformants exhibit increased DNA-dsb rejoining during exposure to ionizing radiation. Oncogene 1998; 16: 1789–1802.

    Article  CAS  Google Scholar 

  25. Lee ST, et al. Bcl-2 targeted to the endoplasmic reticulum can inhibit apoptosis induced by Myc but not etoposide in Rat-1 fibroblasts. Oncogene 1999; 18: 3520–3528.

    Article  CAS  Google Scholar 

  26. Kurts C, et al. Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8(+) T cells. J Exp Med 1997; 186: 239–245.

    Article  CAS  Google Scholar 

  27. Altieri DC . The molecular basis and potential role of survivin in cancer diagnosis and therapy. Trends Mol Med 2001; 7: 542–547.

    Article  CAS  Google Scholar 

  28. Ambrosini G, Adida C, Altieri DC . A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 1997; 3: 917–921.

    Article  CAS  Google Scholar 

  29. Slingerland JM, Tannock IF . Cell proliferation and cell death. In: Tannock IF, Hill RP (eds). The Basic Science of Oncology. 3rd ed. McGraw-Hill: Toronto. 1998. pp. 134–165.

    Google Scholar 

  30. Kaufmann SH, et al. Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res 1993; 53: 3976–3985.

    CAS  PubMed  Google Scholar 

  31. Winter RN, Kramer A, Borkowski A, Kyprianou N . Loss of caspase-1 and caspase-3 protein expression in human prostate cancer. Cancer Res 2001; 61: 1227–1232.

    CAS  PubMed  Google Scholar 

  32. Olive PL . DNA damage and repair in individual cells: applications of the comet assay in radiobiology. Int J Radiat Biol 1999; 75: 395–405.

    Article  CAS  Google Scholar 

  33. Wahl GM, Carr AM . The evolution of diverse biological responses to DNA damage: insights from yeast and p53. Nat Cell Biol 2001; 3: E277–286.

    Article  CAS  Google Scholar 

  34. Giaccia AJ, Kastan MB . The complexity of p53 modulation: emerging patterns from divergent signals. Genes Dev 1998; 12: 2973–2983.

    Article  CAS  Google Scholar 

  35. Carroll AG, Voeller HJ, Sugars L, Gelmann EP . p53 oncogene mutations in three human prostate cancer cell lines. Prostate 1993; 23: 123–134.

    Article  CAS  Google Scholar 

  36. Girinsky T, et al. Attenuated response of p53 and p21 in primary cultures of human prostatic epithelial cells exposed to DNA-damaging agents. Cancer Res 1995; 55: 3726–3731.

    CAS  PubMed  Google Scholar 

  37. Krtolica A, et al. Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging. Proc Natl Acad Sci USA 2001; 98: 12072–12077.

    Article  CAS  Google Scholar 

  38. Leith JT . In vitro radiation sensitivity of the LNCaP prostatic tumor cell line. Prostate 1994; 24: 119–124.

    Article  CAS  Google Scholar 

  39. DeWeese TL, Shipman JM, Dillehay LE, Nelson WG . Sensitivity of human prostatic carcinoma cell lines to low dose rate radiation exposure. J Urol 1998; 159: 591–598.

    Article  CAS  Google Scholar 

  40. Suzuki K, et al. Radiation-induced senescence-like growth arrest requires TP53 function but not telomere shortening. Radiat Res 2001; 155: 248–253.

    Article  CAS  Google Scholar 

  41. Rave-Frank M, et al. In vitro response of human dermal fibroblasts to X-irradiation: relationship between radiation-induced clonogenic cell death, chromosome aberrations and markers of proliferative senescence or differentiation. Int J Radiat Biol 2001; 77: 1163–1174.

    Article  CAS  Google Scholar 

  42. Kamijo T, et al. Loss of the ARF tumor suppressor reverses premature replicative arrest but not radiation hypersensitivity arising from disabled atm function. Cancer Res 1999; 59: 2464–2469.

    CAS  PubMed  Google Scholar 

  43. Chang BD, et al. Molecular determinants of terminal growth arrest induced in tumor cells by a chemotherapeutic agent. Proc Natl Acad Sci USA 2002; 99: 389–394.

    Article  CAS  Google Scholar 

  44. Kyprianou N, King ED, Bradbury D, Rhee JG . bcl-2 over-expression delays radiation-induced apoptosis without affecting the clonogenic survival of human prostate cancer cells. Int J Cancer 1997; 70: 341–348.

    Article  CAS  Google Scholar 

  45. Sheridan MT, West CM . Ability to undergo apoptosis does not correlate with the intrinsic radiosensitivity (SF2) of human cervix tumor cell lines. Int J Radiat Oncol Biol Phys 2001; 50: 503–509.

    Article  CAS  Google Scholar 

  46. Lock RB, Stribinskiene L . Dual modes of death induced by etoposide in human epithelial tumor cells allow Bc1-2 to inhibit apoptosis without affecting clonogenic survival. Cancer Res 1996; 56: 4006–4012.

    CAS  PubMed  Google Scholar 

  47. Aldridge DR, Arends MJ, Radford IR . Increasing the susceptibility of the rat 208F fibroblast cell line to radiation-induced apoptosis does not alter its clonogenic survival dose-response. Br J Cancer 1995; 71: 571–577.

    Article  CAS  Google Scholar 

  48. Meyer KM, Hess SM, Tlsty TD, Leadon SA . Human mammary epithelial cells exhibit a differential p53-mediated response following exposure to ionizing radiation or UV light. Oncogene 1999; 18: 5795–5805.

    Article  CAS  Google Scholar 

  49. Romanov SR, et al. Normal human mammary epithelial cells spontaneously escape senescence and acquire genomic changes. Nature 2001; 409: 633–637.

    Article  CAS  Google Scholar 

  50. Kabalin JN, Peehl DM, Stamey TA . Clonal growth of human prostatic epithelial cells is stimulated by fibroblasts. Prostate 1989; 14: 251–263.

    Article  CAS  Google Scholar 

  51. Camps JL, et al. Fibroblast-mediated acceleration of human epithelial tumor growth in vivo. Proc Natl Acad Sci USA 1990; 87: 75–79.

    Article  CAS  Google Scholar 

  52. Kao GD, McKenna WG, Yen TJ . Detection of repair activity during the DNA damage-induced G2 delay in human cancer cells. Oncogene 2001; 20: 3486–3496.

    Article  CAS  Google Scholar 

  53. Hwang A, Muschel RJ . Radiation and the G2 phase of the cell cycle. Radiat Res 1998; 150: S52–59.

    Article  CAS  Google Scholar 

  54. Gaudin PB, et al. Histopathologic effects of three-dimensional conformal external beam radiation therapy on benign and malignant prostate tissues. Am J Surg Pathol 1999; 23: 1021–1031.

    Article  CAS  Google Scholar 

  55. Pollack A, et al. The early supra-additive apoptotic response of R3327-G prostate tumors to androgen ablation and radiation is not sustained with multiple fractions. Int J Radiat Oncol Biol Phys 2000; 46: 153–158.

    Article  CAS  Google Scholar 

  56. Bolla M, et al. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin. New Engl J Med 1997; 337: 295–300.

    Article  CAS  Google Scholar 

  57. Crook J, et al. Postradiotherapy prostate biopsies: what do they really mean? Results for 498 patients. Int J Radiat Oncol Biol Phys 2000; 48: 355–367.

    Article  CAS  Google Scholar 

  58. Suenaga M, et al. Histone deacetylase inhibitors suppress telomerase reverse transcriptase mRNA expression in prostate cancer cells. Int J Cancer 2002; 97: 621–625.

    Article  CAS  Google Scholar 

  59. Marks PA, Rifkind RA, Richon VM, Breslow R . Inhibitors of histone deacetylase are potentially effective anticancer agents. Clin Cancer Res 2001; 7: 759–760.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors would like to thank Dr L Chung for donating our LNCaP cell line, and Dr L Penn and E Soucie for the Rat-1 HO15.19 cell line. Special thanks to S Al Rashid, C Cantin, and F Jalali for help in selected assays and guidance. These studies were supported by the National Cancer Institute of Canada, the Princess Margaret Hospital Foundation and the US Army DOD Prostate Research Program.

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, University of Toronto and the Ontario Cancer Institute/Princess Margaret Hospital, University Health Network, Toronto, Ontario, Canada

    P Warde & R G Bristow

  2. Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada

    G P Bromfield, A Meng & R G Bristow

Authors
  1. G P Bromfield
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A Meng
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P Warde
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R G Bristow
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to R G Bristow.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bromfield, G., Meng, A., Warde, P. et al. Cell death in irradiated prostate epithelial cells: role of apoptotic and clonogenic cell kill. Prostate Cancer Prostatic Dis 6, 73–85 (2003). https://doi.org/10.1038/sj.pcan.4500628

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.pcan.4500628

Keywords

This article is cited by

Search

Advanced search

Quick links